About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Phoenix | 8,269 Studies Near You

Clinical TrialsPhoenix

Clinical Trials in Phoenix

Discover 8,269 clinical trials near Phoenix, Arizona. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3781-3800 of 8,269 trials

CompletedPeri-device Leakage Closure After LAAOThe investigators thought to evaluate the safety and feasibility of peri-device leakage closure after left atrial appendage occlusion (LAAO, either surgical or interventional)…NCT04590898·Phoenix, Arizona and 15 others CompletedEfficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital HerpesThis study will assess the safety and efficacy of one-day famciclovir (1000 mg twice a day (b.i.d)) in reducing the duration of genital herpes lesions and the associated symptoms…NCT00306787·Birmingham, Alabama and 65 others

Find Trials by Condition in Phoenix

Breast Cancerin Phoenix Lung Cancerin Phoenix Prostate Cancerin Phoenix Colorectal Cancerin Phoenix Melanomain Phoenix Leukemiain Phoenix Lymphomain Phoenix Pancreatic Cancerin Phoenix Ovarian Cancerin Phoenix Brain Cancerin Phoenix Diabetes

Data from ClinicalTrials.govTerms

CompletedA Trial of Restrictive Versus Traditional Blood Transfusion Practices in Burn PatientsThe purpose of this study is to find out if burn injured patients do better receiving fewer blood transfusions than what is traditionally given.NCT01079247·Phoenix, Arizona and 17 others

CompletedBI 10773 (Empagliflozin) Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients (EMPA-REG OUTCOME).The aim of the present study is to investigate the safety of BI 10773 treatment in patients with Type 2 Diabetes Mellitus and high cardiovascular risk.NCT01131676·Birmingham, Alabama and 614 others

CompletedChronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment With Subcutaneous Immunoglobulin (IgPro20)This is a prospective, multicenter, randomized, double-blind, placebo-controlled, parallel-group 3-arm study to investigate 2 different doses of subcutaneous (SC) IgPro20 compared…NCT01545076·Birmingham, Alabama and 90 others

CompletedA 38 Week Trial Comparing Effect and Safety of Insulin Degludec/Insulin Aspart vs. Insulin Glargine Plus Insulin Aspart in Subjects With Type 2 Diabetes Treated With Basal Insulin With or Without Oral Antidiabetic Treatment in Need of Treatment IntensificationTrial comparing effect and safety of insulin degludec/insulin aspart vs. insulin glargine plus insulin aspart in subjects with type 2 diabetes treated with basal insulin with or…NCT02906917·Glendale, Arizona and 70 others

Enrolling by invitationA Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic ArthritisThis is a study to demonstrate the long-term safety, tolerability and clinical efficacy of sonelokimab in the treatment of patients with psoriatic arthritis who completed a…NCT07223138·Avondale, Arizona and 16 others

TerminatedMultiple Dose Escalation Trial Of PF-04603629 Given To Subjects With Type 2 Diabetes MellitusPF-04603629 is being investigated for the treatment of Type 2 diabetes mellitus (T2DM).NCT00637338·Phoenix, Arizona and 3 others

AvailableExpanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-Cel) Out-of-Specification (OOS) in Participants With Multiple MyelomaThe purpose of this expanded access program (EAP) is to provide ciltacabtagene autoleucel (cilta-cel) that does not meet the commercial release specifications of CARVYKTI and is…NCT05346835·Birmingham, Alabama and 137 others

TerminatedEfficacy and Safety Trial of Conbercept Intravitreal Injection for Neovascular AMD (PANDA-2)The purpose of this clinical study is to evaluate the efficacy and safety of two different levels of conbercept intravitreal (IVT) injection as compared to the approved vascular…NCT03630952·Phoenix, Arizona and 153 others

CompletedStudy To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's DiseaseParkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person.NCT04750226·Birmingham, Alabama and 51 others

TerminatedEffects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label ExtensionThis study provides an opportunity for subjects in the REFALS (3119002; NCT03505021) study to continue treatment with oral levosimendan.NCT03948178·Phoenix, Arizona and 78 others

CompletedThe CANTATA-MSU Trial (CANagliflozin Treatment And Trial Analysis - Metformin and SUlphonylurea)The purpose of this study is to evaluate the efficacy and safety of 2 different doses of canagliflozin compared with placebo in patients with type 2 diabetes mellitus who are…NCT01106625·Huntsville, Alabama and 75 others

CompletedVidofludimus Calcium for Primary Sclerosing CholangitisTo examine the safety, tolerability, and efficacy of daily dosing with vidofludimus calcium over a 6-month period.NCT03722576·Phoenix, Arizona and 2 others

RecruitingStudy of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper ExtremitiesThis Phase 3, randomized, multi-center, evaluator-blind, vehicle-controlled study evaluates the efficacy and safety of reformulated Levulan Kerastick (aminolevulinic acid HCl 20%)…NCT07144852·Phoenix, Arizona and 19 others

RecruitingAvapritinib With Decitabine in Patients With SM-AHNSystemic mastocytosis with an associated hematologic neoplasm (SM-AHN) is a challenging disease to treat.NCT06327685·Phoenix, Arizona and 6 others

RecruitingA Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusThe purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long…NCT06617325·Avondale, Arizona and 241 others

UnknownDapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19This is a multi-center, randomized, triple-blind, placebo-controlled (RCT) study to evaluate the efficacy and safety of Dapsone in older adults, and/or in adult patients (≥40yrs…NCT04935476·Phoenix, Arizona and 6 others

TerminatedPhase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitisIzokibep is a small protein molecule that acts as a selective, potent inhibitor of interleukin-17A, to which it binds with high affinity.NCT05384249·Phoenix, Arizona and 68 others

RecruitingPRE-ISPY Phase I/II Oncology Platform ProgramPRE-ISPY Phase I/II (I-SPY-P1) is an open-label, multisite platform study with multiple ongoing drug regimen arms added by protocol amendment which is designed to evaluate single…NCT05868226·Birmingham, Alabama and 9 others

PreviousPage 190 of 414Next

in Phoenix

Heart Diseasein Phoenix